These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 33457131)

  • 1. A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19.
    Morrison N; Barnett K; Tantum J; Morrison HK; Whalen M
    Cureus; 2020 Dec; 12(12):e12029. PubMed ID: 33457131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports.
    Khedr A; Hennawi HA; Khan MK; Eissa A; Mir M; Rauf I; Nitesh J; Surani S; Khan SA
    World J Clin Cases; 2023 Aug; 11(24):5700-5709. PubMed ID: 37727728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
    Zughaib MT; Patel K; Leka M; Affas S
    Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report.
    Batista DV; Vieira CAFA; Costa TA; Lima EG
    Diabetol Int; 2021 Jul; 12(3):313-316. PubMed ID: 33133998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euglycemic diabetic ketoacidosis: A missed diagnosis.
    Nasa P; Chaudhary S; Shrivastava PK; Singh A
    World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
    Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
    Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors be avoided in Covid-19 and other acute Infections?
    Pilianidis G; Papanastasiou G; Tikoudi P; Themistocleous A; Farmakis G; Dolianitis K
    Eur J Case Rep Intern Med; 2024; 11(3):004282. PubMed ID: 38455692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature.
    Reddy PK; Kuchay MS; Mehta Y; Mishra SK
    Diabetes Metab Syndr; 2020; 14(5):1459-1462. PubMed ID: 32771918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.
    Nagdev G; Chavan G; Gadkari C; Sahu G
    Cureus; 2022 Oct; 14(10):e30895. PubMed ID: 36465737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
    Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
    AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Presenting With Diabetic Ketoacidosis: A Case Series.
    Gorthi RS; Kamel G; Dhindsa S; Nayak RP
    AACE Clin Case Rep; 2021; 7(1):6-9. PubMed ID: 33521253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor.
    Jeong SH; Vorachitti M; Fuentes F
    Cureus; 2023 May; 15(5):e39012. PubMed ID: 37378199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report.
    Matli VVK; Fariduddin MM; Asafo-Agyei KO; Bansal N
    Clin Case Rep; 2021 Dec; 9(12):e05144. PubMed ID: 34917366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis.
    Thawabi M; Studyvin S
    N Am J Med Sci; 2015 Jun; 7(6):291-4. PubMed ID: 26199928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euglycemic diabetic ketoacidosis in a patient with new-onset type 1 diabetes following a ketogenic diet: a potential risk of a dangerous dietary trend.
    Helvaci BC; Erdogan BT; Ozdemir D; Topaloglu O; Cakir B
    Arch Endocrinol Metab; 2024; 68():e230229. PubMed ID: 39420895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
    Patel K; Nair A
    Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic diabetic ketoacidosis in the setting of acute intracerebral hemorrhage.
    Lee MKH; Ball PA
    Surg Neurol Int; 2024; 15():284. PubMed ID: 39246790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of New Onset Diabetes and Severe Diabetes Ketoacidosis in a Patient With COVID-19.
    Patel L; Ayad S; Rayad MN; Gergis K; Ejikeme C; Talpur A; Abdelazeem B; Eckman A
    Cureus; 2021 Aug; 13(8):e16923. PubMed ID: 34513494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Euglycemic Diabetic Ketoacidosis Caused by Alcoholic Pancreatitis and Starvation Ketosis.
    Han HJ; Cole AE; Verma A
    J Gen Intern Med; 2023 Apr; 38(5):1299-1301. PubMed ID: 36689144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.